Fluvoxamine for Treating COVID-19

<p>How effective is fluvoxamine in patients with COVID-19? A 2-week course of full-dose fluvoxamine decreased clinical deterioration in outpatients with symptomatic COVID-19 infection.</p> <p>Faculty: Jim Phelps, M.D.<br /> Hosts: Jessica Diaz, M.D.; Lorena Rodríguez, M.D.</p> <ul> <li><strong><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133"> Learn more about Premium Membership here</a></strong></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-30-2604?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133"> <strong>Earn 0.5 CMEs: Quick Take Vol. 30</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19-2604-5082?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133"> <strong>Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19</strong></a></li> </ul>